Pfizer vaccinations for 16 to 39-year-olds is welcome news. But AstraZeneca remains a good option
Importantly, given what we know about the high rates of COVID infections in younger people, and the significant role they're playing in transmission, this is good news. Boosting vaccination rates in this group will be a crucial step towards controlling the virus.
via Economictimes
Post a Comment